Affordable Access

deepdyve-link
Publisher Website

Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney.

Authors
  • Tochigi, Kosuke1
  • Funahashi, Yasuhito1
  • Mori, Aya1
  • Matsukawa, Yoshihisa1
  • Kato, Masashi1
  • Gotoh, Momokazu1
  • 1 Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan. , (Japan)
Type
Published Article
Journal
Nagoya journal of medical science
Publication Date
May 01, 2019
Volume
81
Issue
2
Pages
337–340
Identifiers
DOI: 10.18999/nagjms.81.2.337
PMID: 31239602
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

A 55-year-old man with a solitary kidney was diagnosed with an 8.5 cm renal cell carcinoma in the right kidney without metastasis. Twenty five months of sunitinib treatment reduced the tumor from 8.5 to 5.5 cm and enabled nephron-sparing surgery. He has no evidence of recurrence 58 months after the surgery.

Report this publication

Statistics

Seen <100 times